Concepedia

Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912

Yoshihiro Tadori, Hisashi Kitagawa, Robert A. Forbes, Robert D. McQuade, Arlene Stark, Tetsuro Kikuchi

European Journal of Pharmacology · 2007 · 69 citations · 30 references

DOI

Concepts

References

30

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi Cheng, William H. Prusoff · Biochemical Pharmacology · 1973 · 12.9K citations

, , +14

Relationship Between Dopamine D<sub>2</sub> Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

Shitij Kapur, Robert B. Zipursky, Corey Jones et al. · American Journal of Psychiatry · 2000 · 1.1K citations

, , +17

Pharmacologic Analysis of Drug Receptor Interaction

Kenakin. T. Kenakin · Therapeutic Drug Monitoring · 1988 · 930 citations

, , +17

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Kevin D. Burris, Thaddeus F. Molski, Cen Xu et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 922 citations

, , +16

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

John M. Kane, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2002 · 625 citations

, , +17